Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-05 4:01 pm Purchase | 13G | RENEO PHARMACEUTICALS INC RPHM | Octagon Capital Advisors LP | 2,250,000 6.75% | 2,250,000 (New Position) | View |
| 2024-01-16 5:54 pm Purchase | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners L.P. | 1,694,229 5.1% | 1,694,229 (New Position) | View |
| 2023-12-26 5:00 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | TANG CAPITAL PARTNERS LP | 3,330,000 9.996% | 3,330,000 (New Position) | View |
| 2023-12-15 4:55 pm Sale | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 0 0% | -3,430,377 (Position Closed) | View |
| 2023-05-30 4:52 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III L.P. | 2,534,220 7.53% | 125,000 (+5.19%) | View |
| 2023-05-15 5:16 pm Unchanged | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 3,430,377 10.2% | 0 (Unchanged) | View |
| 2023-05-09 4:31 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | Carlyle Group Inc. CG | 2,730,457 8.2% | 642,500 (+30.77%) | View |
| 2022-09-30 4:45 pm Unchanged | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 3,430,377 14% | 0 (Unchanged) | View |
| 2022-08-11 4:52 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | Carlyle Group Inc. CG | 2,087,957 8.5% | 2,087,957 (New Position) | View |
| 2022-01-27 3:31 pm Unchanged | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 3,430,377 14% | 0 (Unchanged) | View |
| 2022-01-26 4:10 pm Purchase | 13G | RENEO PHARMACEUTICALS INC RPHM | Lundbeckfond Invest A/S | 2,031,224 8.3% | 2,031,224 (New Position) | View |
| 2021-04-23 08:46 am Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | New Enterprise Associates 15 L.P. | 4,785,494 19.8% | 4,785,494 (New Position) | View |
| 2021-04-20 4:07 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | Abingworth LLP | 1,858,226 7.7% | 1,858,226 (New Position) | View |
| 2021-04-19 2:04 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III L.P. | 2,409,220 10% | 2,409,220 (New Position) | View |
| 2021-04-14 4:43 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 3,430,377 14.2% | 3,430,377 (New Position) | View |